BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Faisal Khurshid does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 SYRESpyre Therapeutics Inc. | Buy | $45.00 | Apr 2025 | +279.0% | Hit |
 STTKShattuck Labs Inc | Buy | $4.00 | Mar 2025 | +409.2% | Hit |
 ATYRaTyr Pharma, Inc. | Buy | $16.00 | Feb 2025 | −86.2% | Miss |
 ANIPANI Pharmaceuticals Inc | Buy | $80.00 | Dec 2024 | +34.3% | Hit |
 ZURAZura Bio Limited Class A Ordinary Shares | Buy | $15.00 | Nov 2024 | −16.0% | Miss |
 MNKDMannKind Corp | Buy | $8.00 | Sep 2024 | +1.0% | Miss |
 PRTCPureTech Health PLC | Buy | $45.00 | Sep 2024 | −5.9% | Miss |
 PLRXPliant Therapeutics Inc | Buy | $33.00 | Sep 2024 | −77.0% | Miss |
 GERNGeron Corporation | Buy | $7.00 | Sep 2024 | −59.2% | Miss |
 IMUXImmunic Inc | Buy | $5.00 | Sep 2024 | −32.6% | Miss |
 KYMRKymera Therapeutics Inc | Buy | $60.00 | Sep 2024 | +2.2% | Miss |
 TRVITrevi Therapeutics Inc | Buy | $7.00 | Sep 2024 | +176.8% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.